vs

Side-by-side financial comparison of ARVINAS, INC. (ARVN) and PLUMAS BANCORP (PLBC). Click either name above to swap in a different company.

ARVINAS, INC. is the larger business by last-quarter revenue ($41.9M vs $28.6M, roughly 1.5× PLUMAS BANCORP). On growth, PLUMAS BANCORP posted the faster year-over-year revenue change (35.1% vs -59.1%). PLUMAS BANCORP produced more free cash flow last quarter ($20.3M vs $-59.2M). Over the past eight quarters, PLUMAS BANCORP's revenue compounded faster (20.8% CAGR vs 10.0%).

Arvinas, Inc. is a clinical-stage biotechnology company focused on developing targeted protein degradation therapies, including PROTAC molecules, to treat cancer and rare diseases. It operates primarily in the U.S. and global biopharma markets, advancing multiple pipeline candidates through clinical trials to address unmet medical needs.

Plumas Bancorp is a U.S.-based bank holding company operating through its subsidiary Plumas Bank. It provides full-spectrum retail and commercial banking services including deposit products, consumer and commercial loans, small business financing, and wealth management for individual customers, SMEs and local community groups across northern California and Nevada.

ARVN vs PLBC — Head-to-Head

Bigger by revenue
ARVN
ARVN
1.5× larger
ARVN
$41.9M
$28.6M
PLBC
Growing faster (revenue YoY)
PLBC
PLBC
+94.1% gap
PLBC
35.1%
-59.1%
ARVN
More free cash flow
PLBC
PLBC
$79.5M more FCF
PLBC
$20.3M
$-59.2M
ARVN
Faster 2-yr revenue CAGR
PLBC
PLBC
Annualised
PLBC
20.8%
10.0%
ARVN

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
ARVN
ARVN
PLBC
PLBC
Revenue
$41.9M
$28.6M
Net Profit
$-35.1M
Gross Margin
Operating Margin
-104.5%
48.9%
Net Margin
-83.8%
Revenue YoY
-59.1%
35.1%
Net Profit YoY
28.7%
EPS (diluted)
$-0.48
$1.56

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ARVN
ARVN
PLBC
PLBC
Q4 25
$28.6M
Q3 25
$41.9M
$27.4M
Q2 25
$20.5M
Q1 25
$188.8M
$21.8M
Q4 24
$59.2M
$21.2M
Q3 24
$102.4M
$21.1M
Q2 24
$76.5M
$20.6M
Q1 24
$25.3M
$19.6M
Net Profit
ARVN
ARVN
PLBC
PLBC
Q4 25
Q3 25
$-35.1M
$5.1M
Q2 25
$6.3M
Q1 25
$82.9M
$7.2M
Q4 24
$-45.1M
Q3 24
$-49.2M
$7.8M
Q2 24
$-35.2M
$6.8M
Q1 24
$-69.4M
$6.3M
Operating Margin
ARVN
ARVN
PLBC
PLBC
Q4 25
48.9%
Q3 25
-104.5%
25.2%
Q2 25
42.2%
Q1 25
37.8%
46.1%
Q4 24
-98.1%
50.3%
Q3 24
-58.9%
50.6%
Q2 24
-63.4%
45.1%
Q1 24
-329.2%
42.8%
Net Margin
ARVN
ARVN
PLBC
PLBC
Q4 25
Q3 25
-83.8%
18.8%
Q2 25
30.8%
Q1 25
43.9%
33.0%
Q4 24
-76.2%
Q3 24
-48.0%
37.1%
Q2 24
-46.0%
32.9%
Q1 24
-274.3%
31.9%
EPS (diluted)
ARVN
ARVN
PLBC
PLBC
Q4 25
$1.56
Q3 25
$-0.48
$0.73
Q2 25
$1.05
Q1 25
$1.14
$1.20
Q4 24
$-0.63
$1.30
Q3 24
$-0.68
$1.31
Q2 24
$-0.49
$1.14
Q1 24
$-0.97
$1.05

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ARVN
ARVN
PLBC
PLBC
Cash + ST InvestmentsLiquidity on hand
$787.6M
$80.6M
Total DebtLower is stronger
$600.0K
Stockholders' EquityBook value
$564.4M
$261.1M
Total Assets
$844.3M
$2.2B
Debt / EquityLower = less leverage
0.00×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ARVN
ARVN
PLBC
PLBC
Q4 25
$80.6M
Q3 25
$787.6M
$87.3M
Q2 25
$79.3M
Q1 25
$954.3M
$87.3M
Q4 24
$1.0B
$82.0M
Q3 24
$1.1B
$118.0M
Q2 24
$1.2B
$109.9M
Q1 24
$1.2B
$128.2M
Total Debt
ARVN
ARVN
PLBC
PLBC
Q4 25
Q3 25
$600.0K
Q2 25
Q1 25
$700.0K
Q4 24
$800.0K
Q3 24
$800.0K
Q2 24
$900.0K
Q1 24
$900.0K
Stockholders' Equity
ARVN
ARVN
PLBC
PLBC
Q4 25
$261.1M
Q3 25
$564.4M
$245.9M
Q2 25
$193.1M
Q1 25
$660.1M
$187.6M
Q4 24
$561.7M
$177.9M
Q3 24
$586.0M
$181.9M
Q2 24
$600.2M
$165.2M
Q1 24
$609.7M
$161.5M
Total Assets
ARVN
ARVN
PLBC
PLBC
Q4 25
$2.2B
Q3 25
$844.3M
$2.2B
Q2 25
$1.6B
Q1 25
$1.0B
$1.6B
Q4 24
$1.1B
$1.6B
Q3 24
$1.2B
$1.7B
Q2 24
$1.3B
$1.6B
Q1 24
$1.2B
$1.6B
Debt / Equity
ARVN
ARVN
PLBC
PLBC
Q4 25
Q3 25
0.00×
Q2 25
Q1 25
0.00×
Q4 24
0.00×
Q3 24
0.00×
Q2 24
0.00×
Q1 24
0.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ARVN
ARVN
PLBC
PLBC
Operating Cash FlowLast quarter
$-59.1M
$21.6M
Free Cash FlowOCF − Capex
$-59.2M
$20.3M
FCF MarginFCF / Revenue
-141.3%
70.9%
Capex IntensityCapex / Revenue
0.2%
4.6%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-361.6M
$34.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ARVN
ARVN
PLBC
PLBC
Q4 25
$21.6M
Q3 25
$-59.1M
$5.6M
Q2 25
$2.1M
Q1 25
$-88.9M
$7.5M
Q4 24
$-84.1M
$30.5M
Q3 24
$-128.0M
$8.0M
Q2 24
$50.3M
$5.1M
Q1 24
$-97.5M
$9.2M
Free Cash Flow
ARVN
ARVN
PLBC
PLBC
Q4 25
$20.3M
Q3 25
$-59.2M
$4.8M
Q2 25
$2.0M
Q1 25
$-89.3M
$7.3M
Q4 24
$-84.4M
$29.8M
Q3 24
$-128.7M
$7.8M
Q2 24
$49.6M
$4.8M
Q1 24
$-97.6M
$9.0M
FCF Margin
ARVN
ARVN
PLBC
PLBC
Q4 25
70.9%
Q3 25
-141.3%
17.5%
Q2 25
9.9%
Q1 25
-47.3%
33.7%
Q4 24
-142.6%
141.0%
Q3 24
-125.7%
37.1%
Q2 24
64.8%
23.5%
Q1 24
-385.8%
45.8%
Capex Intensity
ARVN
ARVN
PLBC
PLBC
Q4 25
4.6%
Q3 25
0.2%
2.9%
Q2 25
0.2%
Q1 25
0.2%
0.8%
Q4 24
0.5%
3.2%
Q3 24
0.7%
0.7%
Q2 24
0.9%
1.1%
Q1 24
0.4%
1.0%
Cash Conversion
ARVN
ARVN
PLBC
PLBC
Q4 25
Q3 25
1.09×
Q2 25
0.33×
Q1 25
-1.07×
1.04×
Q4 24
Q3 24
1.02×
Q2 24
0.75×
Q1 24
1.46×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons